NCT03680547

Brief Summary

There are some diseases that give rise to diverse renal manifestations as does sickle cell disease

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
25

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started May 2020

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 20, 2018

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 21, 2018

Completed
1.6 years until next milestone

Study Start

First participant enrolled

May 1, 2020

Completed
29 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2020

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2021

Completed
Last Updated

November 29, 2019

Status Verified

November 1, 2019

Enrollment Period

29 days

First QC Date

September 20, 2018

Last Update Submit

November 27, 2019

Conditions

Sickle Cell Nephropathy

Outcome Measures

Primary Outcomes (1)

  • sickle cell nephropathy in patient with sickle cell disease

    detection of renal impairment in patients with sickle cell disease by estamating gloerular and tubular dysfunction clinicaly and laboratory

    one year

Interventions

patient with sickle cell diseaseOTHER

assess degree of renal affection in patientswith sickle cell disease attending Assuit university Children hospital by estimating some predictors of glomerular and tubular dysfunction.

Eligibility Criteria

Age5 Months - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodProbability Sample
Study Population

to assess degree of renal affection in patients with sickle cell disease attending Assuit university Children hospital by estimating some predictors of glomerular and tubular dysfunction.detailed history taking and thorough clinical examination and laboratory investigations

You may qualify if:

  • All patients with sickle cell anemia attending the unit will be included in the study.

You may not qualify if:

  • patient with any underlaying systemic diseases other than sickle cell anaemia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Hemoglobin, Sickle

Intervention Hierarchy (Ancestors)

Hemoglobins, AbnormalHemoglobinsBlood ProteinsProteinsAmino Acids, Peptides, and ProteinsGlobinsHemeproteins

Study Officials

  • omnia talat hasan

    assiut

    PRINCIPAL INVESTIGATOR

Central Study Contacts

fahim mohamed fahim

CONTACT

01002500073fahim.osman@med.aun.edu.eg

ahlam badawi ali

CONTACT

01006807866ahlam.badawi@med.aun.edu.eg

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assiut

Study Record Dates

First Submitted

September 20, 2018

First Posted

September 21, 2018

Study Start

May 1, 2020

Primary Completion

May 30, 2020

Study Completion

January 1, 2021

Last Updated

November 29, 2019

Record last verified: 2019-11